GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Cash Flow for Lease Financing

LEGN (Legend Biotech) Cash Flow for Lease Financing : $0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Cash Flow for Lease Financing?

Legend Biotech's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was $0.0 Mil. Legend Biotech's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Dec. 2024 ), Legend Biotech's Cash Flow for Lease Financing remained the same in Mar. 2025 ($0.0 Mil).

Legend Biotech Cash Flow for Lease Financing Historical Data

The historical data trend for Legend Biotech's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Cash Flow for Lease Financing Chart

Legend Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Legend Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Legend Biotech Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Legend Biotech Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Cash Flow for Lease Financing
Comparable Companies
NUVL IONS AXSM TGTX ADMA MDGL BBIO PCVX BPMC JAZZ VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
9LB:Germany
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Website
https://www.legendbiotech.com
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.